Track market-moving stories before they get noisy

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© FabrikaSimf / Shutterstock.com

The AI trade everyone talks about is silicon. The AI trade almost nobody talks about is the copper that moves electrons from a substation to a GPU rack, and the Global X Copper Miners ETF (NYSE:COPX) is the cleanest liquid vehicle for owning it. COPX holds the companies digging the stuff out of the ground, and while software valuations stretch over another leg of the buildout, the fund has quietly returned roughly 69% over the past year against about 20% for the S&P 500.

What COPX actually owns and why it matters for AI The fund tracks the Solactive Global Copper Miners index and concentrates in dozens of of large producers. Most of its holdings are foreign companies that directly or indirectly are in the business of mining copper, or at least have decent exposure to it.

The AI link is physical. A single conventional data center requires thousands of tons of copper and megawatts of dedicated power capacity, and the National Electrical Contractors Association told Congress in April that data center energy use could account for 9.1% of all U.S. electricity consumption by the end of the decade.

Every substation, transformer, and foot of high-voltage cable feeding a GPU cluster is copper-intensive. Global copper consumption is expected to move from 26 million tonnes in 2022 toward 43 million tonnes by 2050, driven by AI data centers and electrification.

Does the fund deliver on the thesis? Yes. COPX is up 136% over five years and about 513% over ten, well ahead of the S&P’s 85% and 323% over the same windows. Freeport-McMoRan (NYSE:FCX | FCX Price Prediction), the second-largest U.S. holding, is up roughly 34% over the past year. The biggest U.S. holding is Southern Copper (NYSE:SCCO), up 72% in the past year. The fund pulled in nearly $2 billion in fresh inflows this year, bringing assets to about $7.76 billion.

The 0.65% expense ratio is not cheap next to broad-market ETFs, but no S&P fund gives you this factor. Supply supports the case.

The Democratic Republic of Congo, the world’s second-largest producer, saw Q1 copper exports rise 4.8% and expects little major 2026 output damage from Middle East disruptions. Consolidation is heating up: a South32 asset sale would push copper to roughly 55% of its EBITDA, making it a more obvious takeover target, while BHP’s new CEO inherits the classic copper dilemma of building expensive new mines versus buying existing assets. Miners tend to overpay in that scenario, and COPX owns most of the plausible sellers.

The tradeoffs you actually sign up for Cyclicality is the whole game. COPX is down almost 3% over the past month, a reminder that copper miners crack hard on any whiff of growth wobble. U.S. real GDP swung from 4.4% in mid-2025 to 0.5% in the third quarter to 2.1% into 2026, and copper equities amplify those moves.

Growth sensitivity. If global industrial activity slows, copper miners fall faster than the underlying metal. This fund is a call option on synchronized growth plus the AI capex cycle. Concentration and jurisdiction risk. Half the portfolio sits in five names, and much production comes from Chile, Peru, and the DRC. Permits, royalties, and grid access are political decisions. The technology counterpoint. Jensen Huang argued in June that fiber optics and silicon photonics are becoming increasingly necessary due to the limitations of copper at higher bandwidths. Rack-to-rack interconnects may shift; substation-to-rack copper does not. Who COPX fits and who should skip it COPX fits the profile of a satellite position for investors who already own broad equity index funds and want targeted exposure to the electrification buildout without stock-picking miners. It pairs well against a large software or semiconductor position, capturing the physical bill that the AI story eventually has to pay.

The fund pays little income and swings hard, so it is a poor match for retirees drawing on their portfolio. A 20% drawdown on a bad month of Chinese PMI data is a routine outcome here, which rules it out for anyone who cannot tolerate that volatility. Everyone else gets a genuine picks-and-shovels trade at a fair price, provided they treat it as a cyclical position with a defined exit.

Contact [email protected] for any questions or corrections.

Lucid Group Inc (NASDAQ: LCID) shares are trading higher Monday as a wave of positive momentum continues to build across the electric vehicle sector.

Lucid Group stock is showing exceptional strength. What’s fueling LCID momentum? EV Demand Signals Keep Investor Sentiment ElevatedThe broader EV space is catching a bid as recent delivery and production results reinforce confidence that demand across the sector remains on solid footing. Investors are growing more comfortable rotating into EV names as the fundamental case for electric vehicles strengthens globally.

Fresh data out of the United Kingdom is adding to that constructive tone. Battery electric vehicles captured nearly 30% of new car registrations in June their strongest monthly showing outside of seasonal peaks driven by higher fuel costs, government incentives and a growing lineup of lower-priced models, according to Reuters.

For the year BEVs now account for roughly 25% of all new UK registrations. The data signals that the shift away from combustion engines is broadening beyond early adopters and into the mainstream consumer market a dynamic that benefits the entire EV ecosystem including Lucid.

Critical Levels To Watch for LCID StockMomentum has improved. MACD is above its signal line and the histogram is positive, which shows that downside pressure has eased compared with the prior downswing. When MACD holds above the signal line, it often signals that the recent up‑move is gaining traction even if the larger trend has not fully turned.

Key Resistance: $7.00 — A nearby round‑number level that can cap rebounds and sits just under the 100‑day simple moving average zone. Key Support: $5.50 — A close‑by floor aligned with the 20‑day simple moving average region where buyers have recently stepped in. LCID Shares Are BoomingLCID Price Action: Lucid shares were up 10.03% at $6.69 at the time of publication on Monday, according to Benzinga Pro.

Image: Ian Dewar Photography/Shutterstock.com

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

, /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ZoomInfo Technologies Inc. ("ZoomInfo" or "the Company") (NASDAQ: GTM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between November 3, 2025 and May 11, 2026, inclusive (the "Class Period"), are encouraged to contact the firm before August 24, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. ZoomInfo led investors to believe that it was enjoying growth in both legacy products and AI-driven innovations. The Company's growth plan did not mirror the reality of weakening demand. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about ZoomInfo, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.             

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE The Schall Law Firm

July 06, 2026 16:01 ET  | Source: Vaxart, Inc.

No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reported

SOUTH SAN FRANCISCO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) today announced topline data from the approximately 400-participant sentinel safety cohort of its Phase 2b clinical trial evaluating the Company’s oral pill COVID-19 vaccine candidate against an approved mRNA vaccine comparator. Participants in this safety cohort received Vaxart’s oral pill vaccine (201 participants dosed) or an approved mRNA vaccine (199 participants dosed) targeting the XBB strain of SARS-CoV-2, the virus that causes COVID-19. No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events (AEs) were reported in either arm of the study. Data from the complete study, comprising the 400 dosed participants in the sentinel safety cohort and approximately 5,000 dosed participants in the main cohort, are currently anticipated in 2027. Participants in the main cohort received vaccines targeting the KP.2 viral strain prevalent at the time cohort dosing was initiated.

“These topline safety data are encouraging and are consistent with the safety profile observed to date in other studies of our oral pill vaccine constructs,” said James Cummings, MD, Chief Medical Officer at Vaxart. "We know that safety and tolerability are critical factors in successful vaccine development, and we are pleased with how our investigational vaccine performed in this cohort.”

What did the topline 12-month results from the sentinel safety cohort show?
Key topline 12-month results from the 400-participant sentinel safety cohort (201 oral vaccinees and 199 mRNA vaccinees) include:

No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher AEs were reported in either the oral pill vaccine or mRNA arms of the trial.The most common AEs in participants receiving the oral pill vaccine were malaise/fatigue (20.9%), headache (18.9%) and anorexia (10.0%). Fewer than 10% of participants experienced any other AE.The most common AEs in participants receiving the mRNA vaccine were injection site pain (60.3%), injection site tenderness (40.2%), malaise/fatigue (35.2%), myalgia/muscle pain (33.2%), and headache (28.6%). Arthralgia, chills, anorexia, nausea, diarrhea, and induration/swelling at the injection site were experienced by between 10-15% of participants. Fewer than 10% of participants experienced any other AE.With respect to the efficacy measure of symptomatic COVID, 33 participants in Vaxart’s oral pill vaccine arm and 30 participants in the injectable mRNA vaccine arm had symptomatic disease. Asymptomatic COVID cases were reported in 12 participants in the Vaxart oral pill arm and 12 in the mRNA vaccine arm. It should be noted that this 400-participant sentinel safety cohort was not powered to determine comparative efficacy between the two arms.Topline data from the complete study, comprising the 400 participants in the sentinel safety cohort and approximately 5,000 participants in the main cohort, are anticipated in 2027. The main cohort is designed and powered to support the planned statistical comparison of safety and relative efficacy outcomes between the two arms. “These first cohort topline data are an important advancement for our COVID-19 program and for our oral pill vaccine platform overall,” said Steven Lo, Chief Executive Officer at Vaxart. “This study adds to the body of evidence supporting the safety profile of our vaccine constructs as we look to demonstrate the potential of our proprietary oral delivery technology. We believe more insights into our oral COVID program are important and will be further analyzing this cohort as we eagerly await the readout from the main cohort of this trial, which is expected to provide more robust information on safety and efficacy.”

Funding for this award was received under Project NextGen, an initiative by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), and the National Institute of Allergy and Infectious Diseases (NIAID) to accelerate and streamline the development of the next generation of innovative COVID-19 vaccines, therapeutics, and enablers. Vaxart’s project award through the Rapid Response Partnership Vehicle (RRPV) Consortium is valued at up to $344.8 million. This project has been funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA), under Other Transaction Number: 75A50123D00005.

About Vaxart 
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.

Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Vaxart's strategy, prospects, plans and objectives, results from preclinical and clinical trials and the timing of such results, and beliefs and expectations of management, including statements regarding Vaxart’s Phase 2b clinical trial of its oral pill COVID-19 vaccine candidate, the 400-participant sentinel safety cohort, the approximately 5,000-participant main cohort, further analyses of trial data, anticipated timing of complete study data, and funding under Project NextGen and the RRPV Consortium, are forward-looking statements. These forward-looking statements may be accompanied by such words as "should," "believe," "could," "potential," "will," "expected," “anticipate,” "plan," “intend,” “may,” “estimate,” “approximately,” “designed,” “powered,” “subject to,” and other words and terms of similar meaning. Examples of such statements include, but are not limited to, statements relating to Vaxart's ability to develop its product candidates and oral pill vaccine platform; Vaxart's expectations regarding clinical results and trial data, and the timing of receiving and reporting such clinical results and trial data, including further analyses of the sentinel safety cohort and complete study data anticipated in 2027; Vaxart’s expectations regarding the design, powering, conduct, completion and analysis of its Phase 2b COVID-19 trial and main cohort; and Vaxart’s expectations with respect to the safety, tolerability, efficacy, relative efficacy, immunogenicity and potential regulatory significance of its product candidates, as well as the availability, permitted uses and sufficiency of funding under the Project NextGen/BARDA/RRPV award. These forward-looking statements are based on Vaxart’s current expectations and assumptions as of the date of this press release. Vaxart may not actually achieve the plans, carry out the intentions, or meet the expectations or projections disclosed in the forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations, and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Vaxart makes, including uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, retain participants, collect follow-up data, generate sufficient evaluable cases and events, and complete, unblind, analyze and report data from the Phase 2b trial, including the main cohort, in the expected timeframes, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data, including analyses that may differ from or not confirm the topline data from the sentinel safety cohort or may not support conclusions regarding safety, tolerability, immunogenicity, efficacy or relative efficacy; the risk that clinical trial data, including data from the sentinel safety cohort and main cohort, are subject to differing interpretations and assessments by Vaxart, investigators, independent safety reviewers, funding agencies, regulatory authorities and other third parties; whether regulatory authorities will be satisfied with the design of and results from the clinical studies, including the study’s comparator, endpoints, statistical assumptions, strain selection, safety database and efficacy analyses; decisions by regulatory authorities impacting labeling, manufacturing processes, and safety that could affect the availability or commercial potential of any product candidate, including the possibility that Vaxart's product candidates may not be approved, authorized or licensed by the FDA or non-U.S. regulatory authorities; and that results from the Phase 2b trial may not be sufficient to support regulatory submissions, regulatory interactions, approval, authorization, licensure or commercialization of Vaxart’s oral pill COVID-19 vaccine candidate; risks related to government funding for the Phase 2b trial, including whether amounts under the Project NextGen/BARDA/RRPV award will be available, released, reimbursed or sufficient in the amounts or at the times expected, and whether the award may be modified, reduced, delayed, suspended or terminated or subject to conditions, audits or other compliance requirements; that Vaxart or its partners may experience manufacturing, supply, storage, shipment, stability, quality control or quality assurance issues and delays due to events within, or outside of, Vaxart's or its partners' control; difficulties in production, particularly in scaling up initial production, including difficulties with production costs and yields, quality control, including stability of the product candidate and quality assurance testing, shortages of qualified personnel or key raw materials, and compliance with strictly enforced federal, state, and foreign regulations; Vaxart's ability to obtain sufficient capital to fund its operations on terms acceptable to Vaxart, if at all, including expenses not covered by government funding; the impact of changes in government public-health, procurement and funding priorities; changes in COVID-19 incidence, circulating variants, vaccination recommendations and market demand; and competition from approved and investigational COVID-19 vaccines and other vaccine technologies; and other risks described in the “Risk Factors” sections of Vaxart’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings filed with or furnished to the SEC. Vaxart does not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact
Vaxart Media and Investor Relations: 
FINN Partners
[email protected]

HomeIndustriesComputers/ElectronicsTech StocksTech StocksThe president recommended that people buy Dell computers while speaking about the launch of ‘Trump accounts’ on MondayUpdated July 6, 2026, 4:14 p.m. ET

Dell Technologies’ stock got another bump from President Donald Trump on Monday as he spoke about the launch of a new type of investment account for children.

Shares of the electronics maker DELL closed up 4.4% on Monday, but they had risen as much as 8.9% earlier in the session, according to Dow Jones Market Data. That came after the president thanked company founder Michael Dell for his investment in “Trump accounts” and advised people to “go out and buy a Dell computer.”

, /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM), a leading digital and AI transformation company, will host a conference call at 8:00 a.m. ET, on Thursday, August 6, 2026, to discuss its second quarter 2026 financial results. A news release containing these results will be issued before the call. 

The conference call will be live on the EPAM website at https://investors.epam.com. 

Please visit the website at least 15 minutes before the call to register for the event. For those who cannot attend the live webcast, a replay will be available in the Investor Relations section of the website. 

About EPAM Systems, Inc.
EPAM (NYSE:EPAM) is a global leader in AI transformation engineering and integrated consulting, serving Forbes Global 2000 companies and ambitious startups. With over thirty years of expertise in custom software, product and platform engineering, EPAM empowers organizations to become AI-Native enterprises, driving measurable value from innovation and digital investments. Recognized by industry benchmarks and leading analysts as a leader in AI, EPAM delivers globally while engaging locally, making the future real for clients, partners, and employees. 

We are proud to be recognized by Forbes, Glassdoor, Newsweek, Time Magazine, Great Place to Work and kununu as a Most Loved Workplace around the world. 

Learn more at www.epam.com and follow us on LinkedIn.

Forward-Looking Statements
This press release includes estimates and statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Our estimates and forward-looking statements are mainly based on our current expectations and estimates of future events and trends, which affect or may affect our business and operations. These statements may include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions. Those future events and trends may relate to, among other things, developments relating to the war in Ukraine and escalation of the war in the surrounding region, political and civil unrest or military action in the geographies where we conduct business and operate, difficult conditions in global capital markets, foreign exchange markets, global trade, and the broader economy, the adoption and implementation of artificial intelligence technologies by EPAM and its clients, and the effect that these events may have on client demand and our revenues, operations, access to capital, and profitability. Other factors that could cause actual results to differ materially from those expressed or implied include general economic conditions, the risk factors discussed in the Company's most recent Annual Report on Form 10-K and the factors discussed in the Company's Quarterly Reports on Form 10-Q, particularly under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" and other filings with the Securities and Exchange Commission. Although we believe that these estimates and forward-looking statements are based upon reasonable assumptions, they are subject to several risks and uncertainties and are made based on information currently available to us. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.

SOURCE EPAM Systems, Inc.

Investment will enable Tacoma assembly alongside Tundra, Sequoia and rear axles

, /PRNewswire/ -- Toyota Motor North America (TMNA) announced it will invest $3.6 billion to expand its San Antonio manufacturing campus with a second vehicle assembly line to support the Tacoma truck. The expansion will create 2,000 new, high-quality jobs and add 2.5 million square feet to Toyota Texas, doubling its size by 2030.

TMNA will transition Tacoma production from Toyota Motor Manufacturing Baja California (TMMBC) to the expanded Toyota Texas plant over an approximate four-year period.

Toyota Announces $3.6B Expansion, 2,000 New Jobs at its San Antonio Plant - Investment will enable Tacoma assembly alongside Tundra, Sequoia and rear axles. "Toyota's continued investment in North America is a testament to our confidence in the region's workforce, innovation and long-term growth potential," said President and CEO Ted Ogawa, TMNA. "By expanding our San Antonio plant, we are deepening our commitment to American manufacturing, creating meaningful and sustainable jobs, while advancing our mission to deliver high-quality vehicles that meet the changing needs of customers today and into the future."

After a highly competitive process, this expansion highlights Toyota's commitment to Texas as a vital hub for automotive innovation and manufacturing excellence.

"Texas is where the world builds bigger, and Toyota shows it once more with a $3.6 billion expansion in San Antonio that doubles their factory footprint and creates 2,000 new jobs," said Texas Governor Abbott. "This Texas-sized investment reflects the strength of our workforce and the unmatched business advantages found only in our state. Supported by the Texas Enterprise Fund and JETI program, this expansion will deliver economic opportunities to generations of San Antonio families and further cement Texas as the premier destination for world-class advanced manufacturing."

This latest investment will add another assembly line to the campus at Toyota Texas, which already includes a vehicle assembly line and new rear axle plant that is nearing startup.

"We are so proud of Team Texas and what they have accomplished over the past two decades," said Frank Voss, group vice president of truck manufacturing, TMNA and president of Toyota Texas. "The 2,000 acres of South Texas ranchland our plant stands on today was purposefully selected for its ability to scale with vehicle demand, and today marks the first step toward realizing that potential. We're excited to add the beloved Tacoma to our existing award-winning lineup, and we thank the State of Texas, Bexar County and City of San Antonio for their longstanding support."

This expansion brings Toyota's total investment in San Antonio to $8.3 billion since breaking ground in 2003. The new facility will enable increased flexibility for the plant through advanced manufacturing technologies and will align with Toyota's broader North American operations. Toyota remains committed to its operations throughout the U.S., Canada, and Mexico, and encourages a quick resolution to USMCA to make the North American region globally competitive.

"Toyota has been a loyal and dedicated partner in this community for two decades," said Bexar County Judge Peter Sakai. "This is the plant's second milestone investment in two years. Toyota continues to honor its commitments here, and this exciting initiative shows the confidence one of the world's leading companies has in Bexar County today and in the future."

Toyota's local workforce will climb to approximately 6,000 team members, supported by 23 on-site suppliers and their employees.

"San Antonio proudly hosts Toyota, and we're excited to be selected for additional expansion," said San Antonio Mayor Gina Ortiz Jones. "This is a significant recognition of the talent our city offers, as well as the investments our community is willing to make to support Toyota's growth. We look forward to expanding the Toyota family in San Antonio."

For nearly 20 years, Toyota Texas has rolled out top-quality trucks and SUVs, assembling more than 197,000 vehicles last year alone. The San Antonio plant is the exclusive home of the Tundra and Sequoia, both assembled on the same production line, and will begin production at its new rear axle facility this fall.

ADDITIONAL QUOTES

U.S. Senator John Cornyn: "Today's approval of a new Toyota assembly line in San Antonio is great news for Bexar County and Texas as a whole," said Sen. Cornyn. "This $3.6-billion investment will create 2,000 new, well-paying jobs and bring expanded economic opportunities to South Central Texas, and I applaud Toyota for growing their already significant presence in the Lone Star State even further."

U.S. Senator Ted Cruz: "Texas leads the nation because we believe in free enterprise, low taxes, and fewer government barriers to job creators. Congratulations to Toyota on their $3.6 billion new investment in San Antonio. It is another powerful vote of confidence in our state's workers and pro-growth policies. This expansion will create thousands of high-paying jobs, strengthen American manufacturing, and reinforce Texas as the best place in the country to build, invest, and innovate. I look forward to seeing the opportunities Toyota continues to create for San Antonio and communities across our great state."

Lieutenant Governor, State of Texas, Dan Patrick: "Texas' proven formula of free markets, a stable regulatory environment, and fiscal responsibility is why the Lone Star State remains the best state to do business in America," said Lt. Gov. Dan Patrick. "Toyota's new $3.6 billion investment in Bexar County is yet another important data point supporting that fact. This transformational investment for a new Toyota manufacturing line will result in billions in economic activity for the local San Antonio economy and will provide over 2,000 high-paying jobs for families in San Antonio and the surrounding communities."

Texas Speaker of the House, Dustin Burrows: "The State of Texas is proud to strengthen its partnership with Toyota Motor Manufacturing Texas through the announcement of this new San Antonio facility," said Speaker Dustin Burrows. "This investment reflects the confidence that world-class employers like Toyota continue to have in Texas' pro-business climate and skilled workforce. We are grateful for the good-paying jobs and economic opportunities this facility will bring to the region, and we look forward to building on Texas' partnership with Toyota."

Texas State Representative, John Lujan: "As a lifelong resident of San Antonio, I have seen firsthand the impact Toyota has made over the past two decades. Toyota has become an essential part of our city's identity, and this new investment will continue Toyota's legacy of uplifting our Southside residents, breaking cycles of poverty, and providing lasting skills and good-paying jobs. It is truly an honor to work alongside Toyota's leadership, Governor Abbott, Bexar County, and the City of San Antonio to bring this success to our community. I congratulate Toyota on this milestone, which will continue to create opportunity and strengthen South San Antonio for generations to come."

Texas State Senator, Roland Gutierrez: "Toyota Motor Manufacturing Texas' decision to expand in San Antonio is tremendous news for our community and for the State of Texas. The creation of 2,000 new jobs and an economic impact of more than $3.6 billion reflects the strength of our workforce, our business-friendly environment, and the opportunities that continue to grow in our region. This investment adds to the vibrancy of our city and will enhance our area for generations to come. Toyota believes in San Antonio and is proud to invest in the people who make our community such a remarkable place to live and work. We look forward to strengthening our partnership and celebrating continued success together."

Southwest ISD Superintendent, Dr. Jeanette Ball: "Many of our Southwest ISD families have a real, personal connection to Toyota's investment in our community. We're proud to play a role in supporting their expansion and the opportunity it brings to our families." 

President and CEO, greater:SATX Regional Economic Partnership, Sarah Carabias Rush: "This marks a transformational expansion for Toyota in San Antonio. With a second vehicle assembly line, Toyota will continue to grow quality jobs with tremendous career progression opportunities for our San Antonio region," said Sarah Carabias Rush, president and CEO of greater:SATX Regional Economic Partnership. "This win reflects the competitive strength of our skilled workforce, our leadership in automotive manufacturing innovation and the seamless collaboration among the State of Texas, Bexar County, the City of San Antonio and our utility and infrastructure partners to secure this opportunity."

About Toyota

Toyota (NYSE:TM) has been a part of the cultural fabric in the U.S. for nearly 70 years, and is committed to advancing sustainable, next-generation mobility through our Toyota and Lexus brands, plus our nearly 1,500 dealerships.   

Toyota directly employs approximately 48,000 people in the U.S. who have contributed to the design, engineering, and assembly of more than 36 million cars and trucks at our 11 manufacturing plants. In 2025, Toyota's plant in North Carolina began to assemble automotive batteries for electrified vehicles. 

To help inspire the next generation for careers in advanced manufacturing, Toyota launched its in-person tour booking platform and virtual tour experience at www.TourToyota.com allowing guests to schedule a live tour to see several of our U.S. manufacturing facilities in action or visit all plants virtually from anywhere around the globe. 

For more information about Toyota, visit www.ToyotaNewsroom.com. 

Media Contact:
Melinda Louden
210-748-6103
[email protected]

SOURCE Toyota Motor North America

The automaker will boost vehicle production at its San Antonio truck and SUV plant.

© Maja Hitij / Getty Images News via Getty Images

Robert Greifeld, who was NASDAQ’s CEO from 2003 to 2017, used a July 6, 2026, CNBC interview to flag what he calls the largest lockup expiration in the history of U.S. capital markets. His warning centers on SpaceX, whose recently completed offering was the largest IPO ever and now sits at a $2 trillion valuation. He believes the scale of insider stock that’s about to become tradeable is absolutely unprecedented and could play a considerable role in the overall market’s near-term performance.

An $800 Billion Wave of SpaceX Stock Is About to Hit the Market Greifeld framed the setup this way: “SpaceX was the largest IPO ever. But let’s remember it’s been in business for 23, 24 years… it’s really the largest lockup expiration ever. Between now and the end of October there’s around $800 billion of shares that can come onto the market. We’ve never seen anything like that.”

That figure, roughly $800 billion in SpaceX shares eligible to trade between now and the end of October, dwarfs any prior mega-IPO unlock. For context, standard lockup agreements typically run 180 days after the date of the prospectus, during which insiders cannot sell, pledge, or hedge their positions. Once that window closes, supply hits the market all at once.

The wrinkle Greifeld emphasized is who is selling. Because SpaceX operated as a private company for 23 to 24 years before its offering, early backers are sitting on decades of compounded returns in the private market. As he put it: “If you’re a long-term investor in private shares and you’re sitting on a 20 times return, you might not care if you get a 19.5 times return or 21 times return. So you’re going to have some price-insensitive sellers coming to the market over the next 5 to 6 months.”

Why Greifeld Wants SpaceX Added to Major Indexes Quickly Greifeld also pushed back on the notion that SpaceX should wait its turn for major-index membership. “I certainly believe SpaceX belongs in the index as soon as possible. The rules did not contemplate a company that had been around for 23 years that would be worth $2 trillion. Why would that not be in the index?”

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Intercontinental Exchange didn't make the cut. Grab the names FREE today.

Passive inflows tied to index inclusion could partially offset new supply coming from the lockup expiration.

Why the SpaceX IPO Matters for NYSE and NASDAQ Where mega-listings land shapes revenue for the exchange operators. Intercontinental Exchange (NYSE:ICE | ICE Price Prediction), parent of the NYSE and NASDAQ’s primary rival for large listings, reported Q1 2026 adjusted EPS of $2.35, beating the $2.26 consensus, on revenue of $2.98 billion. Listings revenue reached $128 million, up 5% year-over-year, and the exchanges segment grew 30% year-over-year to $1.78 billion. CEO Jeff Sprecher told investors, “We are pleased to report record first quarter results, driven by the strength of our diversified platform.”

ICE shares closed at $132.99 on July 2, 2026, down 17.32% year-to-date and 25.89% over the trailing year. NASDAQ, meanwhile, is landing sizable foreign issuance, with SK Hynix raising $28 billion.

What to Watch The next 5-6 months will test whether index-inclusion demand and around-the-clock derivative liquidity can absorb an $800 billion supply wave from SpaceX holders sitting on decades of gains. Greifeld believes this supply unlock is bigger than anything the market has seen before.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Intercontinental Exchange didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

July 06, 2026 16:15 ET  | Source: CubeSmart

MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced that the Company will release financial results for the three-month period ended June 30, 2026 after the market close on Thursday, July 30, 2026. An accompanying conference call will be held at 11:00 a.m. ET on Friday, July 31, 2026.

A live webcast of the conference call will be available online from the investor relations page of the Company’s corporate website at investors.cubesmart.com. Telephone participants may join on the day of the call by dialing 1 (833) 461-5787 using conference ID number 574860863. Registered financial analysts participating on the call may avoid delays by pre-registering using the following link: https://events.q4inc.com/analyst/574860863?pwd=XXrIBM1q. A replay of the webcast will be available on the Company’s website following the live event.

About the Company

CubeSmart is a self-administered and self-managed real estate investment trust. CubeSmart owns or manages 1,534 self-storage properties across the United States. According to the 2026 Self Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the U.S.

The Company’s mission is to simplify the organizational and logistical challenges created by the many life events and business needs of its customers – through innovative solutions, unparalleled service, and genuine care. The Company's self-storage properties are designed to offer affordable, easily accessible, and, in most locations, climate-controlled storage space for residential and commercial customers.

For more information about business and personal storage or to learn more about the Company and find a nearby storage property, visit www.cubesmart.com or call CubeSmart toll free at 800-800-1717.

Company Contact:
Josh Schutzer
Senior Vice President, Finance
610-535-5700

Key Takeaways Kratos Defense is expanding unmanned systems and air defense through new contracts and production investments.KTOS grew first-quarter 2026 Unmanned Systems revenues, driven primarily by XQ-58A Valkyrie activity.KTOS faces supply-chain and cost pressures, though 2026 and 2027 EPS estimates project strong growth. Kratos Defense & Security Solutions, Inc.’s (KTOS - Free Report) shares have risen 23.6% over the past year compared with the Zacks Aerospace-Defense Equipment industry’s growth of 22.6%. The company continues to hold a leading position as the U.S. Army's principal supplier of unmanned target drones, with long-term demand supported by consistent U.S. defense budget allocations.
 

Image Source: Zacks Investment Research

Other defense equipment stocks have shown mixed performance over the past year. While Curtiss-Wright (CW - Free Report) has gained 54.7%, AeroVironment (AVAV - Free Report) declined 20.7%. Curtiss-Wright and AeroVironment are specialized defense technology companies that benefit from U.S. military modernization and rising defense spending, rather than being prime defense contractors.

Considering Kratos Defense’s outperformance, investors might be left wondering if this is a good time to add KTOS stock to their portfolio. Let's examine the factors that contributed to the share price gain and assess the stock's investment prospects to make an informed decision.

Tailwinds for KTOS StockKratos Defense is the primary unmanned aerial target drone system provider for the U.S. Air Force, Navy, Army and several allied defense agencies. This position has led to multiple recent contracts and partnerships that are expanding its presence in the global UAS market, including a Counter-UAS award in March 2026 and teaming activity tied to the XQ-58A Valkyrie. In first-quarter 2026, Unmanned Systems revenues increased to $82.6 million from $63.1 million a year earlier, driven primarily by Valkyrie-related activity.

In July 2026, Kratos Defense received an approximate $36 million sole-source contract award for a new air defense missile system. The sole-source nature of the award indicates that Kratos Defense possesses specialized capabilities that the customer considered difficult to replace through competitive bidding, strengthening its reputation as a trusted supplier for sensitive national security programs. The contract also supports higher utilization of the manufacturing capacity that the company has been expanding in recent years, potentially improving operating leverage as production scales.

In June 2026, Kratos Defense announced its plans to significantly increase production capacity for its Spartan line of turbojet engines to support growing demand across missile and loitering munition programs. By increasing annual production capacity to 3,000 engines and investing ahead of demand through internally funded procurement of long-lead materials and supply-chain enhancements, Kratos Defense is improving its ability to deliver at scale while shortening lead times for customers.

Headwinds for KTOSKratos Defense continues to cite supply-chain disruptions and parts availability as industry issues that can delay material receipts and deliveries. Management’s 2026 outlook explicitly assumes potential manufacturing and supply-chain disruptions, parts shortages and continued cost increases. Inventoried costs increased to $225.7 million as of March 29, 2026, from $188.2 million as of 2025-end, consistent with larger lot purchases and long-lead items. Persistently higher input costs or further supply friction could pressure margins and keep cash conversion below investor expectations.

Estimates for KTOS StockThe Zacks Consensus Estimate for 2026 and 2027 earnings per share (EPS) indicates an increase of 30.91% and 42.34%, respectively, year over year. 
 

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Curtiss-Wright’s 2026 and 2027 EPS implies an increase of 14.7% and 11.7%, respectively, year over year. The consensus estimate for AeroVironment’s fiscal 2027 EPS indicates an increase of 4.5% year over year.  

KTOS’ Earnings Surprise HistoryThe company beat on earnings in each of the trailing four quarters, delivering an average surprise of 22.64%.

Image Source: Zacks Investment Research

KTOS’ Return on Equity Lower Than IndustryThe company’s trailing 12-month return on equity of 4.3% is lower than the industry average of 12.47%. Return on equity, a profitability measure, reflects how effectively a company utilizes its shareholders’ funds to generate income.

Image Source: Zacks Investment Research

KTOS Stock Trades at a DiscountIn terms of valuation, KTOS’ forward 12-month price/sales (P/S) is 5.33X, a discount to the industry’s average of 14.62X.

Image Source: Zacks Investment Research

What Should an Investor Do Now?Kratos Defense continues to strengthen its leadership in unmanned systems and air defense through new contract awards, strategic partnerships, and growing demand for its advanced autonomous and missile technologies. The company is also expanding its propulsion manufacturing capabilities, positioning itself to capture rising opportunities in missile, loitering munition, and next-generation defense programs.

Investors who already own this Zacks Rank #3 (Hold) stock may consider retaining their position, considering its price performance and strong earnings growth. Given its poor ROE, new investors may wait and look for a better entry point. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

SAN JOSE, Calif.--(BUSINESS WIRE)--Rambus Inc. (Nasdaq: RMBS), a premier chip and silicon IP provider making data faster and safer, today announced that it will hold a conference call on Monday, July 27, 2026, at 2:00 p.m. Pacific Time to discuss its second quarter fiscal year 2026 results. This call will be webcast and can be accessed via Rambus' website at investor.rambus.com. A replay will be available following the call on the Rambus Investor Relations website or for one week at the followi.

NEW YORK--(BUSINESS WIRE)--Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced that it will release financial results for the second quarter ended June 30, 2026 following the close of the market on August 4, 2026. The company will host a conference call and a live webcast to discuss its financial results. The conference call will begin at 5:00 p.m. Eastern Time on August 4, 2026, and can be accessed by dialing 1-833-630-1956 (U.S.

Bronstein, Gewirtz and Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm PR News

If you sold common stock of ChampionX between February 29, 2024 and April 1, 2024 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.

Click here to participate in the action.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) --

What’s Happening?

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ:CHX) in the United States District Court for the Southern District of New York on behalf of all persons and entities who sold common stock of ChampionX between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”).Investors have until July 14, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. What are the Allegation Details?

According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share. What are my Next Steps?

If you purchased or otherwise acquired ChampionX shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com.  Attorney advertising.  Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
[email protected]
www.bespc.com

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 6, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in PicS N.V. ("PicS" or the "Company") (NASDAQ: PICS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of PicS who were adversely affected if they purchased the Company's Class A common stock in and/or traceable to its January 30, 2026 initial public offering (the "IPO"). This action is pending in the United States District Court for the Southern District of New York.

Cannot view this video? Visit:
https://www.youtube.com/watch?v=FQIEqld_vCU

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-pics/

PicS investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-ses/?prs=nf to learn more.

CASE DETAILS: According to the Complaint, PicS and certain of its executives are charged with failing to disclose material information in the Offering Documents, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that: (i) in December 2025, the Company determined that its credit assessment procedures were deficient and required enhancement; (ii) following implementation of revised procedures, the Company reclassified approximately R$590 million of exposures from Stage 2 to Stage 3, resulting in an incremental ECL charge of R$88 million for the quarter ended December 31, 2025; (iii) the Company experienced an undisclosed Stage 3 formation rate exceeding 7% in the fourth quarter of 2025, materially departing from the historical trends disclosed in the offering documents; (iv) the offering documents materially overstated the effectiveness of PicS N.V.'s credit models, user data, and underwriting and risk-monitoring capabilities; and (v) prior to the IPO, PicS N.V.'s expansion into riskier business lines had led to deteriorating credit quality, increased default and impairment risk, and adverse financial and operational trends that were expected to continue worsening and materially impact the Company's business and financial results.

The case is FirstFire Global Opportunities Fund, LLC v. PicS N.V., No. 26-cv-04793.

WHAT TO DO? If you invested in PicS and suffered a loss during the relevant time frame, you have until August 4, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304106

Source: Kahn Swick & Foti, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

, /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Commvault Systems Inc. ("Commvault" or the "Company") (NASDAQ: CVLT).

IF YOU SUFFERED A LOSS ON YOUR COMMVAULT INVESTMENTS, CLICK HERE BEFORE JULY 17, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT

What Is The Lawsuit About?
The complaint filed alleges that, between April 29, 2025 and January 26, 2026, Defendants failed to disclose to investors that: (1) Commvault knew or recklessly disregarded the impact that different types of sales would have on its ARR growth; (2) the variation in net ARR growth is strongly based on the type of sale Commvault is making, thus, the Company's projected net new ARR should not have been determined without properly factoring in sale type; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased. 

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

SOURCE Glancy Prongay Wolke & Rotter LLP

Allegro MicroSystems, Inc. is positioned for multiyear growth via automotive, data center, and industrial robotics markets, but shares reflect much of the near-term upside. Key ALGM growth drivers include higher content per vehicle, data center transition to 800-VDC, and an inflection point in robotics/physical AI expected in CY27. ALGM's balance sheet has improved, with leverage down to 0.65x net debt/aEBITDA, supporting strategic M&A, debt reduction, and opportunistic share repurchases.

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately.

Key Takeaways IonQ launched Clavis XG Multiplex to make quantum security deployable across metro fiber networks. IONQ's Clavis XG Multiplex uses existing network infrastructure to reduce long-term cryptographic risk. IonQ launched InSAR capabilities for millimeter-precision ground deformation monitoring. IonQ (IONQ - Free Report) is strengthening its commercial portfolio beyond quantum computing by expanding into quantum cybersecurity and space-based geospatial intelligence. In line with this, the company introduced Clavis XG Multiplex, marking a new addition to its Clavis XG Quantum Key Distribution (“QKD”) portfolio designed to make quantum security deployable across metropolitan fiber networks. 

Clavis XG Multiplex enables high-performance, physics-based key distribution on a customer’s existing network infrastructure without requiring operators to redesign, isolate or dedicate optical networks for quantum security. The result provides a cost-effective way to reduce long-term cryptographic risk across network segments as broader post-quantum cryptography (PQC) migration progresses across the enterprise.

IonQ also commercially launched Interferometric Synthetic Aperture Radar (InSAR) capabilities through its space missions line. The offering enables millimeter-precision ground deformation monitoring with fully automated tasking and data delivery. It enables customers to detect and track physical changes on the Earth's surface with a frequency and scale never previously offered by a commercial SAR provider.

Peer UpdateRigetti (RGTI - Free Report) recently announced the general availability of its 108-qubit quantum system, Cepheus-1-108Q, marking a significant step forward in its scaling roadmap. The system represents the company’s largest modular architecture to date, built using its proprietary chiplet-based design. Rigetti is demonstrating progress in scaling quantum hardware while maintaining performance benchmarks such as 99.1% median two-qubit gate fidelity and 99.9% single-qubit fidelity. 

Quantum Computing Inc. (QUBT - Free Report) is steadily expanding its footprint in applied quantum technologies. The company secured a contract from the National Institute of Standards and Technology to develop thin-film lithium niobate photonic integrated circuits, highlighting its growing capabilities in advanced photonics. Additionally, QUBT won a subcontract linked to NASA Langley Research Center to develop quantum-based techniques for removing solar noise from space-based LiDAR data, reinforcing its role in next-generation aerospace innovation.

IONQ’s Price PerformanceOver the past year, IONQ’s shares have gained 8.6% compared with the industry’s 221.9% growth. 

Image Source: Zacks Investment Research

Expensive ValuationIonQ currently trades at a forward 12-month price-to-sales (P/S) of 54.58X compared with the industry median of 4.45X.

Image Source: Zacks Investment Research

IONQ Stock Estimate TrendIn the past 30 days, its loss per share estimate for 2026 has moved south to $1.07.

Image Source: Zacks Investment Research

IonQ currently has a Zacks Rank #4 (Sell). 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

ROCKLAND, Mass.--(BUSINESS WIRE)--Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, announced the following details for its second quarter 2026 earnings release and conference call: Earnings Release: Thursday, July 16, 2026, after the market close Conference Call (held via Webcast): Friday, July 17, 2026, at 10:00 AM Eastern Time How to Join Webcast: Participants may join the webcast by registering prior to the call via this link: https://events.q4inc.

HONOLULU--(BUSINESS WIRE)--Bank of Hawai‘i Corporation (NYSE: BOH) (the “Company”) will release second quarter 2026 financial results on Monday, July 27, 2026 before the market opens and hold its quarterly conference call at 2:00 p.m. Eastern Time (8:00 a.m. Hawai‘i Time) on the same day. The live call, including a slide presentation, will be accessible on the investor relations link of the Company's website, www.boh.com. The webcast link is https://register-conf.media-server.com/register/BIbf8.

[url="]The Law Offices of Frank R. Cruz[/url] announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired

, /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Peabody Energy Corporation ("Peabody" or "the Company") (NYSE: BTU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between October 14, 2024 and May 4, 2026, inclusive (the "Class Period"), are encouraged to contact the firm before August 24, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Peabody falsely led investors to believe it could reliably predict the ramp-up and growth of its Centurion mine. The Company suffered wide-ranging issues and delays at the Centurion mine. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Peabody investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.             

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE The Schall Law Firm

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that it expects to release first quarter fiscal year 2027 financial results on Tuesday, July 28, 2026 at 1:00 p.m. Pacific Daylight Time (PDT) and 10:00 p.m. Central European Summer Time (CEST). There will be a videoconference to discuss these results at 1:30 p.m. PDT and 10:30 p.m. CEST on the same day. A livestream of the event will be available on the Logitech corporat.